State Of Wyoming Pfizer Inc Transaction History

State Of Wyoming

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $9,877 - $12,829	378 New	378 $10,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $752,162 - $870,234	-20,824 Reduced 99.33%	141 $5,000
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $62,314 - $81,124	1,582 Added 8.16%	20,965 $855,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $21,417 - $27,958	513 Added 2.72%	19,383 $993,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $432,042 - $527,415	9,873 Added 109.74%	18,870 $826,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $352,092 - $417,471	-7,567 Reduced 45.68%	8,997 $472,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $281,316 - $348,586	6,149 Added 59.04%	16,564 $857,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $1,859 - $2,756	-45 Reduced 0.43%	10,415 $615,000
Q3 2021 Feb 14, 2022	BUY	$39.25 - $50.42 $230,122 - $295,612	5,863 Added 127.54%	10,460 $450,000
Q3 2021 Feb 11, 2022	BUY	$39.25 - $50.42 $165,085 - $212,066	4,206 Added 1075.7%	4,597 $198,000
Q2 2021 Feb 11, 2022	BUY	$35.91 - $40.68 $14,040 - $15,905	391 New	391 $15,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.